Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Paula Ministro & Diana Martins. (2017) Fecal biomarkers in inflammatory bowel disease: how, when and why?. Expert Review of Gastroenterology & Hepatology 11:4, pages 317-328.
Read now
Read now
David Cano-Martínez, Irene D. Román, M. Val T. Lobo, Oscar Pastor, Irene Moreno-Villena, Alberto Paradela, Borja Hernández-Breijo, Ma Dolores Fernández-Moreno, Jorge Monserrat, Patricia Sanmartín-Salinas, Javier P. Gisbert & Luis G. Guijarro. (2014) Effect of Infliximab in oxidised serum albumin levels during experimental colitis. Biomarkers 19:8, pages 693-701.
Read now
Read now
Fernando Magro, Paula Sousa & Paula Ministro. (2014) C-reactive protein in Crohn’s disease: how informative is it?. Expert Review of Gastroenterology & Hepatology 8:4, pages 393-408.
Read now
Read now
B. Moum, A. Ekbom, M. H. Vatn, E. Aadland, J. Sauar, I. Lygren, T. Schulz, N. Stray & O. Fausa. (1997) Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93. Scandinavian Journal of Gastroenterology 32:10, pages 1005-1012.
Read now
Read now
Articles from other publishers (31)
Mladen Maksić, Tijana Veljković, Mirjana Cvetković, Marija Marković, Saša Perić, Olivera Marinković & Nataša Zdravković. (2023) Fecal calprotectin: A marker of Crohn's disease activity. Acta Facultatis Medicae Naissensis 40:2, pages 160-170.
Crossref
Crossref
Filippo Vernia, Angelo Viscido, Mirko Di Ruscio, Gianpiero Stefanelli, Marco Valvano & Giovanni Latella. (2021) Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?. Digestion 102:6, pages 833-844.
Crossref
Crossref
Rayna Shentova-Eneva & Tsvetelina Velikova. (2020) Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?. Gastroenterology Insights 11:2, pages 58-71.
Crossref
Crossref
Zsolt SzakácsBeáta CsiszárMátyás NagyNelli FarkasPéter KenyeresAdrienn ErősAlizadeh HussainKatalin MártaAndrea SzentesiMargit Tőkés-FüzesiTímea BerkiÁron VinczeKálmán TóthPéter HegyiJudit Bajor. (2020) Diet-Dependent and Diet-Independent Hemorheological Alterations in Celiac Disease: A Case-Control Study. Clinical and Translational Gastroenterology 11:11, pages e00256.
Crossref
Crossref
Mirko Di Ruscio, Filippo Vernia, Antonio Ciccone, Giuseppe Frieri & Giovanni Latella. (2018) Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?. Inflammatory Bowel Diseases 24:1, pages 78-92.
Crossref
Crossref
Jennifer Damman & K. T. Park. 2017. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
225
232
.
Gudula JAM Boon. (2015) Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?. World Journal of Gastroenterology 21:40, pages 11469.
Crossref
Crossref
David B. Sachar. (2014) Role of Biomarkers in the Study and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:12, pages 2511-2518.
Crossref
Crossref
Bernhard Sauter, Christoph Beglinger, Marc Girardin, Andrew Macpherson, Pierre Michetti, Alain Schoepfer, Frank Seibold, Stephan R. Vavricka & Gerhard Rogler. (2014) Monitoring Disease Activity and Progression in Crohn's Disease. A Swiss Perspective on the IBD Ahead ‘Optimised Monitoring' Recommendations. Digestion 89:4, pages 299-309.
Crossref
Crossref
Jean-Frédéric Colombel, Brian G. Feagan, William J. Sandborn, Gert Van Assche & Anne M. Robinson. (2012) Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease. Inflammatory Bowel Diseases 18:2, pages 349-358.
Crossref
Crossref
Dan Turner, David R. Mack, Jeffrey Hyams, Neal LeLeiko, Anthony Otley, James Markowitz, Yair Kasirer, Aleixo Muise, Cynthia H. Seow, Mark S. Silverberg, Wallace Crandall & Anne M. Griffiths. (2011) C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. Journal of Crohn's and Colitis 5:5, pages 423-429.
Crossref
Crossref
Hong Lu, Lei Lian, Udayakumar Navaneethan & Bo Shen. (2010) Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis†. Inflammatory Bowel Diseases 16:10, pages 1678-1684.
Crossref
Crossref
Farid Ljuca, Adnan Gegic, Nermin N. Salkic & Nada Pavlovic-Calic. (2009) Circulating Cytokines Reflect Mucosal Inflammatory Status in Patients with Crohn’s Disease. Digestive Diseases and Sciences 55:8, pages 2316-2326.
Crossref
Crossref
Ibrahim Masoodi, Rakesh Kochhar, Usha Dutta, Chetana Vaishnavi, Kaushal K Prasad, Kim Vaiphei, Sukhminder Kaur & Kartar Singh. (2009) Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis. Journal of Gastroenterology and Hepatology 24:11, pages 1768-1774.
Crossref
Crossref
J.L. Mendoza & M.T. Abreu. (2009) Biological markers in inflammatory bowel disease: Practical consideration for clinicians. Gastroentérologie Clinique et Biologique 33, pages S158-S173.
Crossref
Crossref
Jost Langhorst, Sigrid Elsenbruch, Julia Koelzer, Andreas Rueffer, Andreas Michalsen & Gustav J Dobos. (2008) Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices. The American Journal of Gastroenterology 103:1, pages 162-169.
Crossref
Crossref
Itta M. Minderhoud, Melvin Samsom & Bas Oldenburg. (2007) What predicts mucosal inflammation in Crohnʼs disease patients?. Inflammatory Bowel Diseases 13:12, pages 1567-1572.
Crossref
Crossref
Javier P. Gisbert, Yago González-Lama & José Maté. (2007) Papel de los marcadores biológicos en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 30:3, pages 117-129.
Crossref
Crossref
Craig A Solem, Edward V LoftusJrJr, William J Tremaine, William S Harmsen, Alan R Zinsmeister & William J Sandborn. (2005) Correlation of C-Reactive Protein With Clinical, Endoscopic, Histologic, and Radiographic Activity in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 11:8, pages 707-712.
Crossref
Crossref
Beatriz Garcia Alvarez & Manuel Matas Docampo. 2005. Measuring Immunity. Measuring Immunity
620
629
.
P. Nos, G. Bastida, V. Garrigues, F. Calvo, M. Ponce, N. Maroto & J. Ponce. (2004) Factores que influyen en la decisión de administrar corticoides sistémicos en la enfermedad de Crohn. Gastroenterología y Hepatología 27:8, pages 444-449.
Crossref
Crossref
Eric B. Staros. (2003) Molecular Discoveries Alter Our View of Inflammatory Bowel Disease. American Journal of Clinical Pathology 119:4, pages 524-539.
Crossref
Crossref
Eric B. Staros, MD. (2003) Molecular Discoveries Alter Our View of Inflammatory Bowel Disease: A Review From Scientific, Clinical, and Laboratory Perspectives. American Journal of Clinical Pathology 119:4, pages 524-539.
Crossref
Crossref
Žarko Babiæ. (2003) Elevated serum values of procollagen III peptide (PIIIP)in patients with ulcerative colitis who will develop pseudopolyps. World Journal of Gastroenterology 9:3, pages 619.
Crossref
Crossref
Stéphane Nahon, Yoram Bouhnik, Anne Lavergne-Slove, Alain Bitoun, Yves Panis, Patrice Valleur, Kouroche Vahedi, Bernard Messing, Claude Matuchansky & Jean-Claude Rambaud. (2002) Colonoscopy Accurately Predicts the Anatomical Severity of Colonic Crohn's Disease Attacks: Correlation With Findings From Colectomy Specimens. American Journal of Gastroenterology 97:12, pages 3102-3107.
Crossref
Crossref
Alicja Wiercińska-Drapało, Robert Flisiak & Danuta Prokopowicz. (2001) EFFECT OF ULCERATIVE COLITIS ACTIVITY ON PLASMA CONCENTRATION OF TRANSFORMING GROWTH FACTOR β1. Cytokine 14:6, pages 343-346.
Crossref
Crossref
Susan K. Bunn, W. Michael Bisset, Margaret J.C. Main & Barbara E. Golden. (2001) Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 32:2, pages 171-177.
Crossref
Crossref
Xavier Garcia-Moll, Josep Guindo & Juan Carlos Kaski. (2001) Proteína C reactiva como factor de riesgo coronario. Medicina Clínica 117:8, pages 303-308.
Crossref
Crossref
G. M. Hyde & D. P. Jewell. (2003) The management of severe ulcerative colitis. Alimentary Pharmacology & Therapeutics 11:3, pages 419-424.
Crossref
Crossref
Keith Leiper, Ian J. London & Jonathan M. Rhodes. (1997) 9 Management of the first presentation of severe acute colitis. Baillière's Clinical Gastroenterology 11:1, pages 129-151.
Crossref
Crossref
S Almer, G Bodemar, M Ström, E Lindström, P-O Nyström & L Franzén. (1996) Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis. The Lancet 347:9017, pages 1731-1735.
Crossref
Crossref